Medi-Caps Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors considered and approved these results, which include the Statement of Assets and Liabilities and Cash Flow Statement, along with a limited review report. These financial statements provide a snapshot of the company’s performance and financial position.
Financial Performance Overview
Medi-Caps Limited has officially declared its unaudited financial results for both the standalone and consolidated operations, covering the quarter and half-year periods concluding on September 30, 2026. This significant announcement was made following the Board of Directors’ meeting on November 4, 2026.
Key Financial Statements Presented
The disclosed financial results encompass a comprehensive set of statements, including:
- The Un-audited Standalone and Consolidated Financial Results for the specified periods.
- The Statement of Assets and Liabilities.
- The Cash Flow Statement.
- A Limited Review Report accompanying these financial disclosures.
These documents offer insight into the company’s financial health and operational outcomes during the reporting periods. The Board also noted that the financial results would be submitted in XBRL mode and published on the company’s website and the Stock Exchange website, as well as in leading newspapers.
Source: BSE
